PharmaResearch buys US maker CG USA to localize Rejuran and expand Americas

PharmaResearch has acquired US manufacturer CG USA, according to a Chosunbiz report. The deal is intended to localize Rejuran production in the United States and expand the company’s Americas business. Publicly available information does not include transaction value, timeline, or capacity plans. What is clear is that CG USA is positioned as a US manufacturing asset, with Rejuran localization named as the acquisition’s purpose. For B2B buyers and brand operators, the development may affect lead times, regulatory registrations, minimum order requirements, and pricing; until more details emerge, regional supply changes should be part of supplier evaluation.